Cargando…

Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab

Detalles Bibliográficos
Autores principales: Thavendiranathan, Paaladinesh, Amir, Eitan, Bedard, Philippe, Crean, Andrew, Paul, Narinder, Nguyen, Elsie T, Wintersperger, Bernd J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043661/
http://dx.doi.org/10.1186/1532-429X-16-S1-P273
_version_ 1782318957873594368
author Thavendiranathan, Paaladinesh
Amir, Eitan
Bedard, Philippe
Crean, Andrew
Paul, Narinder
Nguyen, Elsie T
Wintersperger, Bernd J
author_facet Thavendiranathan, Paaladinesh
Amir, Eitan
Bedard, Philippe
Crean, Andrew
Paul, Narinder
Nguyen, Elsie T
Wintersperger, Bernd J
author_sort Thavendiranathan, Paaladinesh
collection PubMed
description
format Online
Article
Text
id pubmed-4043661
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40436612014-06-17 Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab Thavendiranathan, Paaladinesh Amir, Eitan Bedard, Philippe Crean, Andrew Paul, Narinder Nguyen, Elsie T Wintersperger, Bernd J J Cardiovasc Magn Reson Poster Presentation BioMed Central 2014-01-16 /pmc/articles/PMC4043661/ http://dx.doi.org/10.1186/1532-429X-16-S1-P273 Text en Copyright © 2014 Thavendiranathan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Thavendiranathan, Paaladinesh
Amir, Eitan
Bedard, Philippe
Crean, Andrew
Paul, Narinder
Nguyen, Elsie T
Wintersperger, Bernd J
Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title_full Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title_fullStr Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title_full_unstemmed Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title_short Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
title_sort regional myocardial edema detected by t2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043661/
http://dx.doi.org/10.1186/1532-429X-16-S1-P273
work_keys_str_mv AT thavendiranathanpaaladinesh regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT amireitan regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT bedardphilippe regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT creanandrew regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT paulnarinder regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT nguyenelsiet regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab
AT winterspergerberndj regionalmyocardialedemadetectedbyt2mappingisafeatureofcardiotoxicityinbreastcancerpatientsreceivingsequentialtherapywithanthracyclinesandtrastuzumab